Resource type 'Experimental Assay Type'

Related resources

41 Resources visible to you, out of a total of 45

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: DENSE-R-CHOP-14

Study: DENSE-R-CHOP-14

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: DENSE-R-CHOP-14

Study: DENSE-R-CHOP-14

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: RICOVER-60

Study: RICOVER-60

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: RICOVER-60

Study: RICOVER-60

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: RICOVER-noRTh

Study: RICOVER-noRTh

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: RICOVER-noRTh

Study: RICOVER-noRTh

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SEXIE-R-CHOP-14

Study: SEXIE-R-CHOP-14

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SEXIE-R-CHOP-14

Study: SEXIE-R-CHOP-14

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SMARTE-R-CHOP-14

Study: SMARTE-R-CHOP-14

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SMARTE-R-CHOP-14

Study: SMARTE-R-CHOP-14

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Pegfilgrastim

Study: Pegfilgrastim

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Pegfilgrastim

Study: Pegfilgrastim

The primary goal of this study was to identify genetic loci associated with steroid hormone levels (cortisol, DHEA-S, testosterone, estradiol, progesterone, 17-hydroxyprogesterone, androstenedione, and aldosterone). In a secondary analysis, we searched for causal effects of steroid hormones on coronary artery disease.

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: OMICS Investigations

Study: GWAS Steroid Hormones

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: MInT

Study: MInT

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: MegaCHOEP

Study: MegaCHOEP

The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.

The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SISPCT

Study: SISPCT

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: SISPCT

Study: SISPCT

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: MAXSEP

Study: MAXSEP

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: MAXSEP

Study: MAXSEP

We are releasing the summary data from our meta-analyses of steroid hormones, to empower other researchers to examine variants or loci in which they are interested for association with these hormonal traits. These data are intended for research purposes only.

Citation: Pott et al. (2019) Genetic Association Study of Eight Steroid Hormones and Implications for Sexual Dimorphism of Coronary Artery Disease. J Clin Endocrinol Metab 104: 5008–5023. PubMed ID: 31169883

When using this data acknowledge ...

No description specified
No description specified

We are releasing the summary data from our GWAS of carotid plaque burden traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.

Citation:

When using this data acknowledge the source as follows: 'Data on carotid plaque burden has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/31 '

For any ...

This assay bundles all synthetic FHIR data of the PhenoMan evaluation. The data arised from a subset of a Synthea(TM) generated data set. We truncated some resource types like Encounter and Provider to reduce the size of the data set and to speed up the import in a FHIR health data store.

Summary statistics from GWAS of baPWV, bfPWV, cfPWV All samples (adjusted for age, sex and log_sys)

These data is intended for research purposes only.

Citation: tbc

When using this data acknowledge the source as follows: 'Data on PWV has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/34'

For any enquiries about the datasets, please contact Michael Rode (michael.rode@imise.uni-leipzig.de) or Markus Scholz (markus.scholz@imise.uni-leipzig.de) ...

Submitter: Michael Rode

Resource type: Genome Wide Association

Technology type: SNP Array

Investigation: OMICS Investigations

Study: GWAS Pulse Wave Velocity

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Covid-19

Study: Covid-19 Data Source Research

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Covid-19

Study: Covid-19 Data Source Research

Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universität Bonn: Anna Böhmer, Prof. Ulrich Jaehde Universitätsklinikum Bonn: Katharina Karsten Dafonte, Dr. med. Martin Coenen, Prof. Hartmann Bonn: Fr. Karsten Dafonte, Dr. med. Coenen, Prof. Hartmann

Submitter: Frank A. Meineke

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Testdata

Study: FHIR Testdata

Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universitätsklinikum Hamburg-Eppendorf: Dr. Jan Gewehr, Dr. Friederike Salman, Yvonne Lemke, Norman Freier, Dr. Steffen Härterich

Submitter: Frank A. Meineke

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Testdata

Study: FHIR Testdata

Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universität Erlangen-Nürnberg: Prof. Fromm, Prof. Maas, Pauline Dürr, Melanie Then, Wahram Andrikyan

Submitter: Frank A. Meineke

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Testdata

Study: FHIR Testdata

Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universitätsklinikum Schleswig-Holstein, Campus Kiel: Prof. Ingolf Cascorbi, Dr. Ruwen Böhm, Felix Rottmann, Dr. Claudia Bulin

Submitter: Frank A. Meineke

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Testdata

Study: FHIR Testdata

Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universität Freiburg: Thomas Maulhardt, Prof. Martin Boeker

Submitter: Frank A. Meineke

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: Testdata

Study: FHIR Testdata

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: ACT-2

Study: ACT-2

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: ACT-2

Study: ACT-2

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: FLYER

Study: Flyer

No description specified

Submitter: René Hänsel

Resource type: Experimental Assay Type

Technology type: Technology Type

Investigation: FLYER

Study: Flyer

We are releasing the summary data from our GWAMA of phytosterol traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.

Citation: tba

When using this data acknowledge the source as follows: 'Data on phytosterol X has been contributed by LIFE investigators and has been downloaded from https://www.health-atlas.de/assays/53.'

For any enquiries about ...

To provide data input and result from a scRNA-Seq integration workflow

We are releasing the summary data from our GWAMA of PCSK9 levels, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.

Citation: tba

When using this data acknowledge the source as follows: 'Data on PCSK9 has been downloaded from https://www.health-atlas.de/data_files/551.'

For any enquiries about the datasets, please contact Janne Pott (janne.pott@imise.uni-leipzig.de) ...

Submitter: Janne Pott

Resource type: Experimental Assay Type

Technology type: SNP Array

Investigation: OMICS Investigations

Study: GWAMA PCSK9

Powered by
(v.1.12.0-master)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

By continuing to use this site you agree to the use of cookies